CaliforniaAB 5542025-2026 Regular SessionHouse

Health care coverage: antiretroviral drugs, drug devices, and drug products.

Sponsored By: Matt Haney (Democratic), Mark Mark González (Democratic)

Vetoed

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsors

  • Matt Haney

    Democratic • House

  • Mark Mark González

    Democratic • House

Cosponsors

  • Corey Jackson

    Democratic • House

  • Greg Wallis

    Republican • House

  • Christopher Ward

    Democratic • House

  • Scott Wiener

    Democratic • Senate

Roll Call Votes

All Roll Calls

Yes: 215 • No: 2

House vote 9/10/2025

Item 245 — Assembly AFLOOR

Yes: 69 • No: 1

Senate vote 9/9/2025

Item 232 — Senate SFLOOR

Yes: 31 • No: 0

legislature vote 8/29/2025

Vote in CS61

Yes: 6 • No: 0

legislature vote 8/18/2025

Vote in CS61

Yes: 7 • No: 0

legislature vote 7/16/2025

Vote in CS60

Yes: 9 • No: 0

House vote 6/3/2025

Item 163 — Assembly AFLOOR

Yes: 68 • No: 1

legislature vote 5/23/2025

Vote in CX25

Yes: 11 • No: 0

legislature vote 4/29/2025

Vote in CX08

Yes: 14 • No: 0

Actions Timeline

  1. Consideration of Governor's veto stricken from file.

    1/22/2026House
  2. Consideration of Governor's veto pending.

    10/13/2025House
  3. Vetoed by Governor.

    10/13/2025House
  4. Enrolled and presented to the Governor at 3 p.m.

    9/22/2025legislature
  5. Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 69. Noes 1. Page 3221.).

    9/10/2025House
  6. In Assembly. Concurrence in Senate amendments pending.

    9/9/2025House
  7. Read third time. Passed. Ordered to the Assembly. (Ayes 31. Noes 0. Page 2664.).

    9/9/2025Senate
  8. Read second time. Ordered to third reading.

    9/8/2025Senate
  9. Read third time and amended. Ordered to second reading.

    9/4/2025Senate
  10. Read second time. Ordered to third reading.

    8/29/2025Senate
  11. From committee: Do pass. (Ayes 6. Noes 0.) (August 29).

    8/29/2025Senate
  12. In committee: Referred to suspense file.

    8/18/2025Senate
  13. Read second time and amended. Re-referred to Com. on APPR.

    7/17/2025Senate
  14. From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (July 16).

    7/17/2025Senate
  15. From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH.

    6/24/2025Senate
  16. Referred to Com. on HEALTH.

    6/18/2025Senate
  17. In Senate. Read first time. To Com. on RLS. for assignment.

    6/4/2025Senate
  18. Read third time. Passed. Ordered to the Senate. (Ayes 68. Noes 1. Page 2007.)

    6/3/2025House
  19. Read second time. Ordered to third reading.

    5/27/2025House
  20. Read second time and amended. Ordered returned to second reading.

    5/23/2025House
  21. From committee: Amend, and do pass as amended. (Ayes 11. Noes 0.) (May 23).

    5/23/2025House
  22. Assembly Rule 63 suspended. (Ayes 51. Noes 16. Page 1644.)

    5/23/2025House
  23. In committee: Set, first hearing. Referred to suspense file.

    5/14/2025House
  24. From committee: Do pass and re-refer to Com. on APPR. (Ayes 14. Noes 0.) (April 29). Re-referred to Com. on APPR.

    4/30/2025House
  25. Re-referred to Com. on HEALTH.

    3/4/2025House

Bill Text

  • Enrolled

    9/12/2025

  • Amended Senate

    9/4/2025

  • Amended Senate

    7/17/2025

  • Amended Senate

    6/24/2025

  • Amended Assembly

    5/23/2025

  • Amended Assembly

    3/3/2025

  • Introduced

    2/11/2025

Related Bills

Back to State Legislation